Latest article: |
Varian Announces Next Generation Dissolution Apparatus
08 Mar 2010: Varian, Inc. announces the availability of its next generation dissolution apparatus designed for testing tablets, capsules and other dosage forms. The 708-DS supports a broad set of applications ranging from manual dissolution testing to automated, high-throughput analysis.
Varian Inc
|
|
|
Recent articles: |
|
Live Cell Imaging of Drug Effects on Golgi Morpholgy Using the CELLview™ Cell Culture Dish
01 Mar 2010: This application note by Greiner Bio-One shows that performing live-cell imaging experiments in parallel in CELLview™ dishes with four compartments allows a direct comparison of the speed and timing of drug effects on the Golgi apparatus. GalNAc-GFP cells can be easily imaged at multiple positions without cell death or focus problems.
Greiner Bio-One GmbH
|
Metrohm Announces New Brochure and Website «Pharmaceutical Analysis»
 22 Feb 2010: Metrohm’s new brochure «Pharmaceutical analysis» is a highly valuable compendium to get an overall view of the most important parameters determining the quality of pharmaceuticals and the methods best suited to check them.
Metrohm AG
|
Protein/Drug Interaction: Ferulic Acid and Bovine Serum Albumin
22 Feb 2010: SPR has been demonstrated to be a powerful optical technique for bioaffinity studies at the solid/solution interface. This application note describes the kinetic studies of ferulic acid and bovine serum albumin (BSA) pre-immobilized onto an alkanethiol self-assembled monolayer (SAM)-modified gold sensor chips.
Biosensing Instrument
|
Establishing a Cell Culture Assay Based on Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) for Screening G-Protein Coupled Receptors
09 Feb 2010: Time-resolved fluorescence resonance energy transfer (TR-FRET) has become a popular technique in the field of high-throughput screening. This application note demonstrates the TR-FRET kit from Cisbio, the IP-One HTRF assay, under standard high-throughput screening conditions. The IP-One HTRF assay was shown to be a stable cell culture time-resolved fluorescence assay for screening G-Protein coupled receptors.
Greiner Bio-One GmbH
|
Tag-lite®: New HTRF® Cellular Platform for Cell Surface Receptors’ Study and Screening
09 Feb 2010: In a recent publication, Maurel et al presented the combination of Cisbio’s HTRF and SNAP-and CLIP- Tag technologies to investigate cell-surface protein-protein interaction. In this study, an application for GPCR oligomerization was accurately documented and the advantages of using the Cisbio HTRF-based cell-surface receptor platform presented. Applications such as highly selective and non-radioactive ligand binding assays are described and the 7TM dimerization model can properly be inv
Cisbio Bioassays
|
Analytica Announces InnovationArea - Start-ups in the spotlight
08 Feb 2010: Analytica will continue its initiative for new companies again in 2010. From March 23 – 26, 2010, international start-ups and research organizations in the biotechnology sector will present their business ideas and document the importance of the life sciences in a special area known as the InnovationArea.
Messe Munchen International
|
AB SCIEX Launches as New Company to Extend Leadership in Analytical Science
04 Feb 2010: AB SCIEX today launched as a new company dedicated to life science analytical technologies. The new company combines the two halves of the highly successful AB SCIEX mass spectrometry joint venture into an integrated organization.
AB SCIEX
|
SBS Announces the Election of New Board Members
 02 Feb 2010: The Society for Biomolecular Sciences (SBS) is pleased to announce the election of two new board members, Melvin Reichman, Ph.D. and Sue Holland-Crimmin, Ph.D. and the re-election of John Wang, Ph.D.. Each will serve a three-year term on the SBS Board of Directors.
Society for Biomolecular Sciences (SBS)
|
Dualsystems Biotech Announces Profiling Service for Reducing Drug Development Time and Overall Development Costs
 28 Jan 2010: A fee-based drug profiling service designed to characterize the mechanism of action and identify off-target effects and novel targets for drugs under development is now available from Dualsystems Biotech AG. This early in-depth profiling of drug candidates helps shorten development time, lowers overall development costs, and results in drugs with a better safety profiles.
Dualsystems Biotech AG
|
adme-toxicology
